Distinguished in Chronic Kidney Disease

Charmaine E. Lok

Hamilton, ON, CA 
Distinguished in Chronic Kidney Disease
Hamilton, ON, CA 
OverviewLocationsClinical Research

Overview

Charmaine Lok practices in Hamilton, Canada. Ms. Lok is rated as a Distinguished expert by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Chronic Kidney Disease, Arteriovenous Malformation, End-Stage Renal Disease (ESRD), Kidney Transplant, and Nephrectomy.

Her clinical research consists of co-authoring 181 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 55 articles in the study of Chronic Kidney Disease.

Gender
Female

Locations

Hamilton, ON, Canada
Other Locations
Toronto, ON, Canada
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Living Kidney Donor Safety Study (Long-term Effects of Becoming a Living Kidney Donor)
The Living Kidney Donor Safety Study (Long-term Effects of Becoming a Living Kidney Donor)
Enrollment Status: Completed
Publish Date: August 06, 2024
Non-Interventional, Exploratory, Phase IV, Single-Blind, Cross-Sectional, Randomised, Cross-over Study Evaluating Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease & Hyperkalaemia (APPETIZE).
Non-Interventional, Exploratory, Phase IV, Single-Blind, Cross-Sectional, Randomised, Cross-over Study Evaluating Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease & Hyperkalaemia (APPETIZE).
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis (SAFE-D)
Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis (SAFE-D)
Enrollment Status: Completed
Publish Date: June 22, 2023
Intervention Type: Drug, Other
Study Drugs: Warfarin, Apixaban
Study Phase: Phase 2
View 2 Less Clinical Trials

181 Total Publications

Strategies to Prevent Hemodialysis Catheter Dysfunction.
Strategies to Prevent Hemodialysis Catheter Dysfunction.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lok's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile